PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-01-28

Date Title Company
28-Jan-2022 3D Cell Culture Conference takes place in less than 2 weeks as a virtual conference SMi Group
28-Jan-2022 Investment in UK biotech jumps 60% to £4.5bn in 2021 BioIndustry Association (BIA) and Clarivate
28-Jan-2022 Dalriada Drug Discovery to Collaborate with atai Life Sciences’ New Platform Company to Discover Next-Generation Therapies for Mental Health Dalriada Drug Discovery
28-Jan-2022 Lipidor Announces Enrolment of First Patients in a Phase III Study on AKP02 for Treatment of Psoriasis Lipidor AB
28-Jan-2022 PHARMACEUTICAL INDUSTRY NEEDS MORE DIGITAL TALENT Association of the British Pharmaceutical Industry
28-Jan-2022 Expert warns 1 in 20 Brits have thyroid disorders: 25% of over-65s are showing abnormalities and 15% of Covid patients develop problems London Medical Laboratory
28-Jan-2022 IAVI and Moderna Launch Trial of HIV Vaccine Antigens Delivered Through mRNA Technology IAVI and Moderna
28-Jan-2022 Cheplapharm AG: TIMETABLE FOR THE PLANNED IPO IS EXTENDED DUE TO UNFAVORABLE MARKET CONDITIONS Cheplapharm AG
28-Jan-2022 Eagle Genomics Selected for Catalonia-Based Initiative to Support Expansion into Spanish-Speaking Markets Eagle Genomics
28-Jan-2022 Generis appoints Head of Life Sciences as CARA™ growth soars Generis
28-Jan-2022 Thermo Fisher Scientific Earns Top Score for LGBTQ+ Workplace Equality for Seventh Consecutive Year Thermo Fisher Scientific
28-Jan-2022 Original-Research: HAEMATO AG (von GBC AG) HAEMATO AG
28-Jan-2022 atai Life Sciences Launches Invyxis to Accelerate Discovery of Next-Generation Mental Health Treatments atai Life Sciences
28-Jan-2022 Orgenesis reaches next milestone in collaboration with Hospital Infantil Universitario Niño Jesús in Madrid Orgenesis Inc.
28-Jan-2022 Novel data in Alzstatin Alzheimer’s project presented at the 11th Pharmaceutical Profiling meeting AlzeCure Pharma AB
28-Jan-2022 4D pharma announces additional positive data from Part A of the Phase I/II trial of MRx-4DP0004 for the treatment of asthma 4D pharma
28-Jan-2022 Key figures for 2021 financial year: COLTENE delivers excellent full-year results thanks to strong demand COLTENE Holding AG